Inventor · disambiguated record
Serge Leger
Also filed as: LEGER SERGE
38 granted patents·18 pending applications·2,847 citations·filing 1987–2021
98Inventor score
Files withMERCK FROSST CANADA INC26SYROS PHARMACEUTICALS INC10REMIX THERAPEUTICS INC4MERCK FROSST CANADA LTD3AXYS PHARM INC2
Top patents by PatentIndex Score
56 records- 0199US5550142APhenyl heterocycles as cox-2 inhibitorsMERCK FROSST CANADA INC·Filed 1995·Granted Aug 27, 1996·379 cites·18 claims
- 0299US5536752APhenyl heterocycles as COX-2 inhibitorsMERCK FROSST CANADA INC·Filed 1995·Granted Jul 16, 1996·383 cites·18 claims
- 0399US5474995APhenyl heterocycles as cox-2 inhibitorsMERCK FROSST CANADA INC·Filed 1994·Granted Dec 12, 1995·543 cites·25 claims
- 0498US5521213ADiaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2MERCK FROSST CANADA INC·Filed 1994·Granted May 28, 1996·331 cites·12 claims
- 0597US5698584A3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhibitorsMERCK FROSST CANADA INC·Filed 1996·Granted Dec 16, 1997·138 cites·18 claims
- 0697US5565473AUnsaturated hydroxyalkylquinoline acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1995·Granted Oct 15, 1996·156 cites·23 claims
- 0796US5840746AUse of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseasesMERCK FROSST CANADA INC·Filed 1997·Granted Nov 24, 1998·91 cites·9 claims
- 0896US5710140APhenyl heterocycles as COX-2 inhibitorsMERCK FROSST CANADA INC·Filed 1996·Granted Jan 20, 1998·156 cites·17 claims
- 0995US5789413AAlkylated styrenes as prodrugs to COX-2 inhibitorsMERCK FROSST CANADA INC·Filed 1997·Granted Aug 4, 1998·77 cites·15 claims
- 1093US11040957B2Heteroaromatic compounds useful for the treatment of proliferative diseasesSYROS PHARMACEUTICALS INC·Filed 2018·Granted Jun 22, 2021·7 cites·21 claims
- 1192US10059690B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·9 cites·19 claims
- 1292US5925631AAlkylated styrenes as prodrugs to COX-2 inhibitorsMERCK & CO INC·Filed 1998·Granted Jul 20, 1999·58 cites·12 claims
- 1390US4851409A2-substituted quinoline dioic acids and pharmaceutical compositionsMERCK FROSST CANADA INC·Filed 1987·Granted Jul 25, 1989·30 cites·9 claims
- 1489US7973037B2Cathepsin cysteine protease inhibitorsAXYS PHARM INC·Filed 2008·Granted Jul 5, 2011·12 cites·10 claims
- 1586US10308648B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2015·Granted Jun 4, 2019·6 cites·20 claims
- 1686US7375134B2Cathepsin cysteine protease inhibitorsAXYS PHARM INC·Filed 2003·Granted May 20, 2008·21 cites·10 claims
- 1785US10106526B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2015·Granted Oct 23, 2018·5 cites·19 claims
- 1885US6222048B1Diaryl-2-(5H)-furanones as Cox-2 inhibitorsMERCK FROSST CANADA INC·Filed 1995·Granted Apr 24, 2001·39 cites·20 claims
- 1985US5204344A(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienesMERCK FROSST CANADA INC·Filed 1991·Granted Apr 20, 1993·30 cites·22 claims
- 2084US10519135B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2018·Granted Dec 31, 2019·3 cites·18 claims
- 2184US5856322AUnsaturated hydroxyalkylquinoline acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1996·Granted Jan 5, 1999·36 cites·18 claims
- 2283US6057319A3,4-Diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitorsMERCK FROSST CANADA INC·Filed 1996·Granted May 2, 2000·34 cites·20 claims
- 2381US5691374ADiaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitorsMERCK FROSST CANADA INC·Filed 1995·Granted Nov 25, 1997·55 cites·18 claims
- 2479US10865206B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2019·Granted Dec 15, 2020·1 cites·25 claims
- 2579US8772336B2Cathepsin cysteine protease inhibitorsMERCK FROSST CANADA INC·Filed 2012·Granted Jul 8, 2014·3 cites·14 claims
- 2679US5428033ASaturated hydroxyalkylquinoline acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1991·Granted Jun 27, 1995·42 cites·17 claims
- 2779US4962203A2-substituted quinolines useful as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1989·Granted Oct 9, 1990·14 cites·9 claims
- 2878US6133292ADiaryl-5-alkyl-5-methyl-2-(5H)-furanones as selective cyclooxygenase-2-inhibitorsMERCK FROSST CANADA INC·Filed 1998·Granted Oct 17, 2000·21 cites·10 claims
- 2976US6486194B2Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseasesMERCK FROSST CANADA INC·Filed 2001·Granted Nov 26, 2002·7 cites·6 claims
- 3076US5994379ABisaryl COX-2 inhibiting compounds, compositions and methods of useMERCK FROSST CANADA INC·Filed 1999·Granted Nov 30, 1999·44 cites·16 claims
- 3175US7582633B2Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA L L C·Filed 2008·Granted Sep 1, 2009·4 cites·19 claims
- 3272US8318748B2Cathepsin cysteine protease inhibitorsBAYLY CHRISTOPHER I·Filed 2011·Granted Nov 27, 2012·2 cites·18 claims
- 3372US5272145A(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienesMERCK FROSST CANADA INC·Filed 1992·Granted Dec 21, 1993·38 cites·27 claims
- 3470US6071954A(methylsulfonyl)phenyl-2-(5H)-furanones with oxygen link as COX-2 inhibitorsMERK FROSST CANADA INC·Filed 1998·Granted Jun 6, 2000·17 cites·13 claims
- 3565US2021061803A1Inhibitors of cyclin-dependent kinase 7 (cdk7)SYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3664US6329421B1Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2MERCK FROSST CANADA INC·Filed 1995·Granted Dec 11, 2001·18 cites·17 claims
- 3764US5374635AFuro[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of leukotriene biosynthesisMERCK FROSST CANADA INC·Filed 1993·Granted Dec 20, 1994·16 cites·11 claims
- 3862US2014256743A1Cathepsin cysteine protease inhibitorsMERCK FROSST CANADA LTD·Filed 2014·Application pending·0 cites
- 3960US5380850A(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienesMERCK FROSST CANADA INC·Filed 1993·Granted Jan 10, 1995·20 cites·3 claims
- 4060US2016264551A1Heteroaromatic compounds useful for the treatment of prolferative diseasesSYROS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4158US2024287097A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4258US2023159496A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4358US2024279239A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4457US2023167093A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4556US2009270434A1Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturaseLEBLANC YVES·Filed 2009·Application pending·0 cites
- 4653US2016264552A1Heteromaromatic compounds useful for the treatment of prolferative diseasesSYROS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4751US2019292167A1Heteroaromatic compounds useful for the treatment of proliferative diseasesSYROS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4850US2010063013A1Cathepsin cysteine protease inhibitorsOBALLA RENATA·Filed 2008·Application pending·0 cites
- 4947US2010152208A1Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA LTD·Filed 2008·Application pending·0 cites
- 5044US2009118296A1Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 DesaturaseMERCK FROSST CANADA LTD·Filed 2006·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Serge Leger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →